4th Donor Selection and Cell Source Summit

Memo

Spearheading Development of Gold Standard Donor Screening, Testing and Management to De-Risk Manufacturing, Improve Product Consistency and Performance and Meet Clinical Demand of High Quality Donor Material For Allogeneic Cell Therapies URLs:Tickets: https://go.evvnt.com/3796513-2?pid=5569Brochure: https://go.evvnt.com/3796513-3?pid=5569 Date and Time: On Mon, 07 Dec 2026 08:00 - Tue, 08 Dec 2026 18:00 Venue Details: The Westgate Hotel, 1055 Second Avenue, San Diego, California, 92101, United States Category: Conferences | Science, Health and Medicine | Pharmaceuticals Price:Vendor - Conference Only: USD 3899.00 Speakers: Cokey Nguyen, President and Chief Executive Officer, Atara Biotherapeutics Inc., Valerie Wall, Senior Scientist and Contractor - Product Sciences, Bristol Myers Squibb, Akshata Ijantkar, Senior Principal Scientist, Analytical Development Lead, Bristol Myers Squibb, Enrique Zudaire, SVP TR, Caribou Biosciences, Nidhi Shah, Senior Manager, Manufacturing Operations, Cellectis, Sanjeev Luther, President and Chief Executive Officer, Ernexa Therapeutics, Robin White, Deputy Technical Director, ICCBBA, Afua Achampong-Duku, Senior Manager, Procurement, Immatics Gmbh, Ruoxi Pi, Senior Scientist, ImmuneBridge, Kimberly Zai, Machine Learning and Data Engineer, ImmuneBridge, Stefanie Mandl-Cashman, Chief Scientific Officer, Indapta Therapeutics, Ali Turhan, Chief Medical Offier, iPSirius, Teresa Montagut, Head of Clinical Development and Medical Affairs, Mesoblast Ltd., Albert Ribickas, Manager, Bloody and Marrow Transplant Laboratory, Clinical Trial and Commercial Product Handling Team, Moffitt Cancer Center, Kok Fei Chan, Research Fellow, Olivia Newton-John Cancer Research Institute, Faraz Siddiqui, Senior Vice President - Technical Operations, Senti Biosciences Inc.